查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2011596

医疗影像设备市场：按产品类型、便携性、应用和最终用户划分－2026-2032年全球市场预测

Diagnostic Imaging Equipment Market by Product Type, Portability, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医疗影像设备市场价值将达到 472.7 亿美元，到 2026 年将成长至 500.1 亿美元，到 2032 年将达到 717.7 亿美元，复合年增长率为 6.14%。

主要市场统计数据
基准年 2025 472.7亿美元
预计年份：2026年 500.1亿美元
预测年份 2032 717.7亿美元
复合年增长率 (%) 6.14%

权威概述了技术创新、不断变化的临床需求和营运要求如何重塑诊断成像设备的采用和使用。

诊断影像设备仍然是现代临床决策的基础，能够实现早期发现、更精准的诊断以及在众多专科领域监测治疗进展。儘管电脑断层扫描 (CT)、磁振造影(MRI)、核子医学影像、超音波和 X 光等影像技术仍然是临床流程的重要组成部分，但不断发展的临床指南和技术进步正日益影响着这些技术的应用和使用模式。相关人员正面临着一个复杂的环境，他们必须在临床疗效、病人安全、成本控制和工作流程优化之间取得平衡，才能创造可衡量的价值。

人工智慧、即时检测 (PoC) 模式、混合成像趋势以及对价值的需求如何从根本上改变诊断成像领域。

诊断影像领域正经历着一场根本性的变革，这场变革是由技术、临床和经济因素共同驱动的。人工智慧（AI）和先进的影像分析技术实现了自动分诊、精准的病灶检测和定量生物标记分析，从而加快了诊断速度并提高了诊断结果的可重复性。同时，混合成像和多模态融合技术将解剖学和功能性数据结合，提高了临床特异性，从而革新了肿瘤学和神经病学领域的诊断演算法。

该评估旨在评估近期关税变化如何重塑诊断成像设备整个价值链的供应链、采购决策和製造策略。

美国于2025年加征关税，为诊断影像设备的全球供应链和筹资策略带来了新的复杂性。依赖跨国采购精密零件和半导体相关子系统的製造商面临投入成本上升和前置作业时间延长的双重压力，迫使他们迅速重新评估供应商集中度带来的风险。为此，许多企业加快了供应商多元化、关键子组件近岸生产以及产品重新设计等倡议，以减少对受关税影响零件的依赖。

从独特的细分观点，探讨影响策略定位的模式差异化、便携性与功能性之间的权衡、临床应用优先顺序以及最终用户的采购行为。

透过对产品类型、便携性、应用和最终用户等细分市场的深入分析，可以明确临床需求与商业性机会的交会点。在产品类型中，电脑断层扫描 (CT) 系统不断发展，高切、中切和低切系统之间的区别决定了其应用场景，从高级血管造影到常规急诊诊断均有涉及。磁振造影(MRI) 系统分为封闭式系统（针对高磁场强度进行最佳化）和开放式系统（优先考虑患者舒适度和介入治疗）。核子医学扫描术诊断分为 PET 和 SPECT 两种模式，其中 PET 在分子肿瘤学领域中保持优势，而 SPECT 则涵盖更广泛的心臟病学和功能性影像适应症。超音波诊断设备的临床应用价值，二维成像用于一般诊断，三维和四维平台用于改善产科和胎儿可视化，多普勒系统用于增强血管和心臟血流效用。 X 光系统正从类比平台向数位放射线摄影过渡，影像工作流程不断改进，并与 PACS 和报告系统整合。

区域医疗保健基础设施、监管碎片化和投资重点如何影响全球市场在采纳和商业策略方面的差异？

区域趋势对整个诊断影像产业的普及曲线、监管方式和创新扩散都产生显着影响。在美洲，完善的医疗基础设施、集中的供应商市场份额和先进的报销机制促进了高端设备和整合软体解决方案的快速普及，而成熟的临床疗效和供应商服务品质往往是系统采购的优先考虑因素。在欧洲、中东和非洲，监管体系的片段化和报销环境的差异导致了普及格局的不平衡。先进治疗方法和高端设备在已开发地区表现良好，而其他市场则更注重成本效益高且性能稳定的解决方案。部分地区的政策转变和集中采购进一步影响定价和竞标行为。在亚太地区，对医疗基础设施的投资、不断增长的临床需求以及有利的公共卫生政策正在加速高端设备和可携式诊断影像解决方案的普及，部分市场对本地生产伙伴关係和以价值为导向的服务交付的需求尤为强劲。

对老牌製造商、敏捷创新者和软体颠覆者如何透过伙伴关係、服务和模组化产品策略来塑造竞争动态进行了深入分析。

诊断影像领域的竞争格局呈现出多元化的特点，既有成熟的跨国製造商，也有专注于特定领域的创新企业，还有越来越多以「软体优先」为核心、致力于分析和工作流程优化的新兴参与企业。现有医疗设备製造商继续强调软硬体一体化解决方案、全生命週期服务合约以及融资方案，以降低大规模医疗机构采用这些产品的门槛。同时，中小企业和Start-Ups透过专注于特定临床应用、推出创新外形规格（例如手持式超音波设备）以及开发可部署为云端服务的先进影像处理演算法来脱颖而出。

供应商和提供者应采取切实可行、优先考虑且具有策略意义的行动，以推动创新、降低供应链风险，并使他们的经营模式与临床结果保持一致。

产业领导企业应采取多管齐下的策略，平衡创新、供应链韧性和以客户为中心的经营模式。优先投资软体和分析技术，既能创造差异化的临床价值，又能透过订阅服务实现持续收入。同时，供应商多元化、近岸外包或评估区域製造伙伴关係关係，可以降低贸易中断和投入成本波动带来的风险。领导者也应重新思考传统的销售方式，提供可客製化的资金筹措、基于绩效的合约以及全面的管理服务包，使奖励与医疗服务提供者的绩效目标保持一致。

结合相关人员访谈、临床文献分析和情境检验的稳健混合方法研究途径，确保了可靠且可操作的见解。

支持这些发现的研究结合了定性和定量方法，采用结构化的调查方法，透过证据三角验证确保结果的可重复性。主要研究包括对临床医生、采购负责人、生物医学工程师和行业高管进行结构化访谈，从而获得关于设备使用、维护週期和采购决策标准的第一手观点。次要研究涵盖了同行评审的临床研究、监管指导文件、製造商的技术规范和公开的财务资讯披露，这些资料共同用于评估该技术的成熟度、临床效用和运营限制。

本文简要总结了决定诊断成像领域竞争成功和临床影响的技术、营运和政策因素的融合。

总而言之，诊断影像设备产业正处于一个转折点，技术进步、医疗服务模式的演变以及价值链的现实变化共同作用，重新定义了价值创造。软体、影像分析和可携式硬体的创新正在开闢新的临床应用场景，并推动分散式医疗工作流程的发展。同时，筹资策略也越来越受到整体拥有成本 (TCO)、与临床结果的契合度以及服务连续性的驱动。贸易政策和关税的变化凸显了供应链多元化的重要性，加速了区域製造的讨论，并为采购和产品设计决策增添了策略维度。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：医疗影像设备市场：依产品类型划分

  • 电脑断层扫描（CT）扫描仪
    • 高切CT扫描仪
    • 低切CT扫描仪
    • 中切CT扫描仪
  • 磁振造影造影（MRI）
    • 封闭式磁振造影系统
    • 开放式磁振造影系统
  • 核子医学扫描术诊断设备
    • PET系统
    • SPECT系统
  • 超音波系统
    • 二维超音波系统
    • 3D和4D超音波系统
    • 多普勒超音波系统
  • X射线系统
    • 模拟X射线系统
    • 数位X射线系统

第九章：诊断影像设备市场－便携性

  • 固定式影像诊断设备
  • 携带式影像设备
    • 手持便携设备
    • 便携式设备

第十章：医疗影像设备市场：依应用领域划分

  • 循环系统
    • 冠状动脉成像
    • 血管影像
  • 神经病学
    • 脑部扫描
    • 脊髓成像
  • 妇产科
    • 胎儿监护
    • 骨盆腔影像诊断
  • 肿瘤学
    • 早期检测
    • 疾病分期和后续观察
  • 整形外科
    • 骨折检测
    • 联合检查

第十一章 医疗影像设备市场：依最终用户划分

  • 门诊部
  • 诊断影像中心
  • 医院和诊所

第十二章 医疗影像设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 医疗影像设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 医疗影像设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国医疗影像设备市场

第十六章：中国医疗影像设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agfa-Gevaert Group
  • Analogic Corporation
  • Avonix Imaging, LLC by Nikon Corporation
  • Barco NV
  • Bracco SpA
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • Konica Minolta, Inc.
  • Koninklijke Philips NV
  • Medtronic PLC
  • MinFound Medical Systems Co., Ltd.
  • Neusoft Corporation
  • Planmed Oy
  • Samsung Electronics Co., Ltd
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • Shenzhen SONTU Medical Imaging Equipment Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers
  • Stryker Corporation
  • Ziehm Imaging GmbH
Product Code: MRR-43676CF420BD

The Diagnostic Imaging Equipment Market was valued at USD 47.27 billion in 2025 and is projected to grow to USD 50.01 billion in 2026, with a CAGR of 6.14%, reaching USD 71.77 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 47.27 billion
Estimated Year [2026] USD 50.01 billion
Forecast Year [2032] USD 71.77 billion
CAGR (%) 6.14%

An authoritative overview of how technological innovation, clinical demand shifts, and operational imperatives are reshaping diagnostic imaging equipment adoption and use

Diagnostic imaging equipment continues to serve as the backbone of modern clinical decision-making, enabling earlier detection, more accurate diagnoses, and better treatment monitoring across a broad range of specialties. Imaging modalities such as computed tomography, magnetic resonance imaging, nuclear imaging, ultrasound, and X-ray remain integral to care pathways, while evolving clinical guidelines and technological advances are increasingly shaping procurement and utilization patterns. Stakeholders are navigating a complex environment where clinical efficacy, patient safety, cost containment, and workflow optimization must be balanced to deliver measurable value.

Clinical demands are being redefined by a confluence of demographic shifts and rising chronic disease prevalence, which together increase imaging volumes and place renewed emphasis on throughput and efficiency. At the same time, technological innovations-ranging from hardware miniaturization to software-driven image enhancement-are altering the value proposition of equipment investments. Providers and vendors must therefore consider not only capital cost but also lifecycle service models, integration with electronic health records, and the ability to support multidisciplinary care. Given this landscape, executives and clinical leaders need a clear, evidence-based picture of how modality-specific advances, regulatory changes, and reimbursement pressures will influence procurement strategies and operational priorities going forward.

How artificial intelligence, point-of-care modalities, hybrid imaging trends, and value-based imperatives are fundamentally altering the diagnostic imaging landscape

The diagnostic imaging landscape is undergoing fundamental transformation driven by converging technological, clinical, and economic forces. Artificial intelligence and advanced image analytics are enabling automated triage, enhanced lesion detection, and quantitative biomarkers that can accelerate diagnosis while improving reproducibility. Concurrently, hybrid imaging and multimodal integration are increasing clinical specificity by combining anatomical and functional data, which is transforming diagnostic algorithms in oncology and neurology.

Meanwhile, the push toward patient-centric care is promoting portable and point-of-care imaging solutions that decongest centralized radiology suites and bring diagnostic capability closer to bedside and community settings. Value-based reimbursement models are also reshaping purchase and service contracts, with providers placing greater emphasis on demonstrable outcomes, throughput, and total cost of ownership rather than acquisition price alone. Lastly, an increased focus on radiation dose optimization, environmental sustainability, and ergonomic design is influencing both product development and procurement criteria. As a result, companies that align product roadmaps with software-driven workflows, interoperability standards, and flexible commercial models are best positioned to capitalize on these transformative shifts.

Assessing how recent tariff shifts have reshaped supply chains, procurement decisions, and manufacturing strategies across the diagnostic imaging equipment value chain

The implementation of tariffs by the United States in 2025 introduced a new layer of complexity to global diagnostic imaging supply chains and procurement strategies. Manufacturers that relied on cross-border sourcing for precision components and semiconductor-dependent subsystems faced increased input costs and longer lead times, prompting rapid reassessment of supplier concentration risks. In response, many organizations accelerated efforts to diversify suppliers, nearshore production of critical subassemblies, and redesign products to reduce dependence on tariff-impacted parts.

Healthcare providers and equipment distributors experienced pressure to renegotiate purchase terms and service agreements, as cost pressures were often transferred through the supply chain. Capital expenditure committees became more sensitive to total lifecycle cost implications and to the balance between immediate capital outlay and long-term service commitments. At the same time, some vendors pursued vertical integration and strategic partnerships to secure critical inputs and stabilize pricing. Regulatory compliance and customs-related administrative burdens also increased, raising the importance of trade expertise in procurement and contracting. Overall, the tariff environment catalyzed supply chain resilience initiatives, reshaping vendor relationships and accelerating manufacturing localization strategies that will influence procurement negotiation dynamics and product roadmaps in the medium term.

Distinctive segmentation-driven perspectives on modality differentiation, portability trade-offs, clinical application priorities, and end-user procurement behaviors influencing strategic positioning

Interpreting segmentation insights across product type, portability, application, and end-user dimensions provides clarity on where clinical needs and commercial opportunity intersect. Within product categories, computed tomography systems continue to evolve with distinctions between high-slice, mid-slice, and low-slice systems shaping use cases from advanced cross-sectional vascular studies to routine emergency diagnostics. Magnetic resonance imaging equipment remains divided between closed systems optimized for higher field strengths and open systems that prioritize patient comfort and interventional access. Nuclear imaging splits across PET and SPECT modalities, with PET maintaining strength in molecular oncology and SPECT serving broader cardiology and functional imaging indications. Ultrasound retains broad clinical utility with 2D imaging for general diagnostics, 3D and 4D platforms advancing obstetrical and fetal visualization, and Doppler systems enhancing vascular and cardiac flow assessment. X-ray systems continue their transition from analog platforms to digital radiography, improving image workflow and integration with PACS and reporting systems.

Portability defines a separate axis of differentiation, where fixed imaging equipment supports high-throughput centralized services while portable imaging equipment, spanning handheld devices and transportable units, enables decentralized diagnostics and rapid response in emergency or remote settings. Application-driven segmentation reveals modality adoption aligned to clinical domains: cardiology leverages coronary and vascular imaging for interventional planning and follow-up, neurology applies brain and spinal cord imaging for stroke and degenerative disease management, obstetrics and gynecology emphasize fetal monitoring and pelvic imaging, oncology requires early detection and staging plus ongoing monitoring, and orthopedics depends on fracture detection and joint-focused examinations. End-user segmentation likewise informs procurement cadence and service expectations; ambulatory care centers prioritize cost-effective, rapid turnaround systems, diagnostic imaging centers focus on specialized throughput and modality mix, and hospitals and clinics demand versatile, integrated platforms capable of supporting a wide range of acute and elective procedures. Understanding these segment intersections is critical for product positioning, capital planning, and clinical engagement strategies, as modality choice and configuration directly influence clinical workflow, staffing, and downstream revenue generation.

How regional healthcare infrastructure, regulatory fragmentation, and investment priorities are directing differential adoption and commercial strategies across global markets

Regional dynamics exert significant influence on adoption curves, regulatory approaches, and innovation diffusion across the diagnostic imaging industry. In the Americas, established healthcare infrastructure, consolidated vendor footprints, and advanced reimbursement frameworks support rapid uptake of high-end modalities and integrated software solutions, while systems procurement is often tied to demonstrated clinical outcomes and vendor service quality. In Europe, the Middle East & Africa, regulatory fragmentation and heterogeneous reimbursement environments create a patchwork of adoption, where advanced therapies and high-end devices perform strongly in developed pockets while other markets emphasize cost-effective, robust solutions. Policy shifts and centralized purchasing in some jurisdictions further influence pricing and tendering behaviors. In the Asia-Pacific region, investment in healthcare infrastructure, rising clinical demand, and favorable public health initiatives are driving accelerated adoption of both high-end modalities and portable imaging solutions, with several markets showing particular appetite for localized manufacturing partnerships and value-aligned service offerings.

Cross-region supply chain considerations, clinical training availability, and variations in patient demographics all shape how device lifecycles, service models, and aftermarket support are structured. Vendors and providers operating across regions must therefore calibrate product portfolios, financing options, and clinical education programs to local reimbursement realities and infrastructure constraints. Strategic regional partnerships and adaptable go-to-market models are essential to translate global innovation into sustainable regional adoption and to mitigate risks associated with regulatory changes and trade disruptions.

An incisive view of how incumbent manufacturers, nimble innovators, and software disruptors are shaping competitive dynamics through partnerships, services, and modular product strategies

The competitive landscape in diagnostic imaging is characterized by a mix of established multinational manufacturers, specialized niche innovators, and a growing cohort of software-first entrants focused on analytics and workflow optimization. Incumbent device manufacturers continue to emphasize integrated hardware-software bundles, lifecycle service agreements, and financing solutions that reduce adoption friction for large providers. Simultaneously, smaller firms and startups are carving out differentiation through focused clinical applications, disruptive form factors such as handheld ultrasound, and advanced image processing algorithms that can be deployed as cloud-enabled services.

Strategic partnerships, co-development agreements, and targeted acquisitions have emerged as primary levers for both scale and innovation. Many companies are investing in modular architectures that allow incremental feature upgrades, thereby extending product lifespans and creating recurring revenue through software subscriptions and clinical decision support tools. Aftermarket services and managed equipment programs are gaining prominence as revenue-stable offerings that align vendor incentives with provider uptime and performance. As competition intensifies, market leaders are balancing capital-intensive R&D with go-to-market investments in clinical validation, training programs, and customer success teams to accelerate adoption and capture downstream service revenue.

Practical and prioritized strategic actions that vendors and providers should implement to innovate, de-risk supply chains, and align commercial models with clinical outcomes

Industry leaders should adopt a multi-faceted strategy that balances innovation with supply chain resilience and customer-centric commercial models. Prioritizing investments in software and analytics can create differentiated clinical value while enabling recurring revenue through subscription services. At the same time, diversifying supplier bases and evaluating nearshoring or regional manufacturing partnerships will mitigate exposure to trade disruptions and input-cost volatility. Leaders should also reconsider traditional sales approaches by offering configurable financing, outcome-linked contracts, and comprehensive managed-service packages that align incentives with provider performance goals.

Operationally, building strong clinical validation programs and clinician-focused training will accelerate technology adoption and build long-term loyalty. Vendor teams should invest in interoperability and open-architecture designs to ease integration into heterogeneous hospital ecosystems and to support multi-vendor workflows. Finally, companies must integrate sustainability and dose-optimization features into product roadmaps as procurement committees increasingly weigh environmental and patient-safety credentials. By combining technical innovation with flexible commercial models and resilient operations, industry leaders can capture strategic growth while delivering measurable clinical and financial value to customers.

A robust mixed-methods research approach combining stakeholder interviews, clinical literature analysis, and scenario validation to ensure reliable and actionable insights

The research underpinning these insights blended qualitative and quantitative rigor through a structured methodology designed to triangulate evidence and ensure reproducibility. Primary research included structured interviews with clinicians, procurement officers, biomedical engineers, and industry executives, providing frontline perspectives on modality utilization, maintenance cycles, and purchase decision criteria. Secondary research encompassed peer-reviewed clinical studies, regulatory guidance documents, manufacturer technical specifications, and publicly available financial disclosures, which together informed assessments of technology readiness, clinical utility, and operational constraints.

Data synthesis employed cross-validation techniques to reconcile divergent views and to identify consensus trends. Case studies and real-world implementations were analyzed to extract lessons on deployment barriers and success factors. The methodology also incorporated scenario analysis to stress-test strategic assumptions under differing regulatory and supply chain conditions. Limitations were acknowledged, including variations in local reimbursement practices and the dynamic nature of software-driven innovation, and these were addressed through continuous stakeholder engagement and iterative validation cycles to maintain relevance and accuracy.

A concise synthesis of the converging technological, operational, and policy forces that will determine competitive success and clinical impact in diagnostic imaging

In synthesis, the diagnostic imaging equipment sector is at an inflection point where technological advances, shifting care delivery models, and supply chain realities are jointly redefining value creation. Innovations in software, image analytics, and portable hardware are unlocking new clinical use cases and enabling decentralized care workflows, while procurement strategies are increasingly guided by total cost of ownership, clinical outcome linkage, and service continuity. Trade policy and tariff changes have underscored the importance of supply chain diversification and have accelerated regional manufacturing conversations, adding a strategic layer to procurement and product design decisions.

Organizations that successfully integrate product innovation with resilient operations, flexible commercial frameworks, and clinician-centered implementation plans will gain competitive advantage. Moreover, the ability to validate clinical impact, ensure regulatory compliance across jurisdictions, and provide reliable aftermarket services will determine long-term vendor-provider relationships. As the sector continues to evolve, stakeholders should maintain agility in portfolio planning and prioritize investments that deliver demonstrable clinical benefit and operational efficiency across diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Diagnostic Imaging Equipment Market, by Product Type

  • 8.1. Computed Tomography (CT) Scanners
    • 8.1.1. High-Slice CT Scanners
    • 8.1.2. Low-Slice CT Scanners
    • 8.1.3. Mid-Slice CT Scanners
  • 8.2. Magnetic Resonance Imaging (MRI) Equipment
    • 8.2.1. Closed MRI Systems
    • 8.2.2. Open MRI Systems
  • 8.3. Nuclear Imaging Equipment
    • 8.3.1. PET Systems
    • 8.3.2. SPECT Systems
  • 8.4. Ultrasound Systems
    • 8.4.1. 2D Ultrasound Systems
    • 8.4.2. 3D & 4D Ultrasound Systems
    • 8.4.3. Doppler Ultrasound Systems
  • 8.5. X-Ray Systems
    • 8.5.1. Analog X-Ray Systems
    • 8.5.2. Digital X-Ray Systems

9. Diagnostic Imaging Equipment Market, by Portability

  • 9.1. Fixed Imaging Equipment
  • 9.2. Portable Imaging Equipment
    • 9.2.1. Handheld Portable Devices
    • 9.2.2. Transportable Equipment

10. Diagnostic Imaging Equipment Market, by Application

  • 10.1. Cardiology
    • 10.1.1. Coronary Imaging
    • 10.1.2. Vascular Imaging
  • 10.2. Neurology
    • 10.2.1. Brain Scans
    • 10.2.2. Spinal Cord Imaging
  • 10.3. Obstetrics & Gynecology
    • 10.3.1. Fetal Monitoring
    • 10.3.2. Pelvic Imaging
  • 10.4. Oncology
    • 10.4.1. Early Detection
    • 10.4.2. Staging & Monitoring
  • 10.5. Orthopedics
    • 10.5.1. Fracture Detection
    • 10.5.2. Joint Examination

11. Diagnostic Imaging Equipment Market, by End-User

  • 11.1. Ambulatory Care Centers
  • 11.2. Diagnostic Imaging Centers
  • 11.3. Hospitals & Clinics

12. Diagnostic Imaging Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Diagnostic Imaging Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Diagnostic Imaging Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Diagnostic Imaging Equipment Market

16. China Diagnostic Imaging Equipment Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agfa-Gevaert Group
  • 17.6. Analogic Corporation
  • 17.7. Avonix Imaging, LLC by Nikon Corporation
  • 17.8. Barco NV
  • 17.9. Bracco S.p.A.
  • 17.10. Canon Medical Systems Corporation
  • 17.11. Carestream Health, Inc.
  • 17.12. Esaote S.p.A
  • 17.13. FUJIFILM Holdings Corporation
  • 17.14. GE HealthCare Technologies Inc.
  • 17.15. Hologic, Inc.
  • 17.16. Konica Minolta, Inc.
  • 17.17. Koninklijke Philips N.V.
  • 17.18. Medtronic PLC
  • 17.19. MinFound Medical Systems Co., Ltd.
  • 17.20. Neusoft Corporation
  • 17.21. Planmed Oy
  • 17.22. Samsung Electronics Co., Ltd
  • 17.23. Shanghai United Imaging Healthcare Co., Ltd.
  • 17.24. Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • 17.25. Shenzhen SONTU Medical Imaging Equipment Co., Ltd.
  • 17.26. Shimadzu Corporation
  • 17.27. Siemens Healthineers
  • 17.28. Stryker Corporation
  • 17.29. Ziehm Imaging GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HIGH-SLICE CT SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HIGH-SLICE CT SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HIGH-SLICE CT SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY LOW-SLICE CT SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY LOW-SLICE CT SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY LOW-SLICE CT SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MID-SLICE CT SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MID-SLICE CT SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MID-SLICE CT SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CLOSED MRI SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CLOSED MRI SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CLOSED MRI SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OPEN MRI SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OPEN MRI SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OPEN MRI SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PET SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PET SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PET SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPECT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPECT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPECT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 2D ULTRASOUND SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 2D ULTRASOUND SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 2D ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 3D & 4D ULTRASOUND SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 3D & 4D ULTRASOUND SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 3D & 4D ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DOPPLER ULTRASOUND SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DOPPLER ULTRASOUND SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DOPPLER ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ANALOG X-RAY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ANALOG X-RAY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ANALOG X-RAY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIGITAL X-RAY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIGITAL X-RAY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIGITAL X-RAY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FIXED IMAGING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FIXED IMAGING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FIXED IMAGING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HANDHELD PORTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HANDHELD PORTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HANDHELD PORTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY TRANSPORTABLE EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY TRANSPORTABLE EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY TRANSPORTABLE EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CORONARY IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CORONARY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CORONARY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY BRAIN SCANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY BRAIN SCANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY BRAIN SCANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPINAL CORD IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPINAL CORD IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPINAL CORD IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FETAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FETAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FETAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PELVIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PELVIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PELVIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY EARLY DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY EARLY DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY EARLY DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY STAGING & MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY STAGING & MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY STAGING & MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FRACTURE DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FRACTURE DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FRACTURE DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY JOINT EXAMINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY JOINT EXAMINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY JOINT EXAMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 263. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 275. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 276. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 280. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 281. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 283. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 284. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 285. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 286. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 287. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 288. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 289. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD